These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29405352)

  • 1. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients.
    Villegas JA; Van Wassenhove J; Le Panse R; Berrih-Aknin S; Dragin N
    Ann N Y Acad Sci; 2018 Feb; 1413(1):154-162. PubMed ID: 29405352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
    Aricha R; Mizrachi K; Fuchs S; Souroujon MC
    J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.
    Uzawa A; Kuwabara S; Suzuki S; Imai T; Murai H; Ozawa Y; Yasuda M; Nagane Y; Utsugisawa K
    Clin Exp Immunol; 2021 Mar; 203(3):366-374. PubMed ID: 33184844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
    Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
    Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N
    J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4
    Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G
    Front Immunol; 2020; 11():809. PubMed ID: 32508812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
    Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
    J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.
    Levinson AI; Zheng Y; Gaulton G; Song D; Moore J; Pletcher CH
    Immunol Res; 2003; 27(2-3):399-408. PubMed ID: 12857984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
    Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S
    Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
    J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
    Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.
    Truffault F; Nazzal D; Verdier J; Gradolatto A; Fadel E; Roussin R; Eymard B; Le Panse R; Berrih-Aknin S
    Front Immunol; 2020; 11():782. PubMed ID: 32435245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of interleukin (IL)-21 and CD4
    Alahgholi-Hajibehzad M; Durmuş H; Aysal F; Gülşen-Parman Y; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Clin Exp Immunol; 2017 Nov; 190(2):201-207. PubMed ID: 28671717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of myasthenia gravis: innate immunity signature in pathological thymus.
    Cavalcante P; Cufi P; Mantegazza R; Berrih-Aknin S; Bernasconi P; Le Panse R
    Autoimmun Rev; 2013 Jul; 12(9):863-74. PubMed ID: 23535157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: acetylcholine receptor antibodies and beyond.
    Burde RM
    J Clin Neuroophthalmol; 1981 Mar; 1(1):63-6. PubMed ID: 6213647
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.